Here, we report that pharmacological activation of HIF-1 and genetic overexpression of intestine epithelial HIF-1 markedly improves western diet–induced MASLD in murine models, likely through upregulation of glycolysis, leading to intestine epithelial cell proliferation and enhanced gut barrier function. This evidence concerns the gene HIF1A and metabolic dysfunction-associated steatotic liver disease.